Acumen Pharmaceuticals, Inc. (ABOS)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

6

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Jan-24 7:04 PM View:	18-Jan-24 Sale (Planned) ($10.56K)	Barton Russell Chief Operating Officer		Acumen Pharmaceuticals, Inc. - ABOS	263% 26.7K to 96.87K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:05 PM View:	18-Jan-24 Sale (Planned) ($11.60K)	Siemers Eric Chief Medical Officer		Acumen Pharmaceuticals, Inc. - ABOS	340% 26.7K to 117.58K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:07 PM View:	19-Jan-24 Sale (Planned) ($52.75K)	Oconnell Daniel Joseph President and CEO Director		Acumen Pharmaceuticals, Inc. - ABOS	331% 116.69K to 502.49K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:05 PM View:	18-Jan-24 Sale (Planned) ($15.72K)	Zuga Matt CFO & Chief Business Officer		Acumen Pharmaceuticals, Inc. - ABOS	93% 109.69K to 211.44K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 7:06 PM View:	19-Jan-24 Sale (Planned) ($31.05K)	Meisner Derek M Chief Legal Officer & Corp Sec		Acumen Pharmaceuticals, Inc. - ABOS	306% 26.8K to 108.87K	0	0	--	--	Show Txns Hide Txns